The Relationship Between Eosinophilic Esophagitis and Immunotherapy - 02/04/24
, Maria A. Sacta, MD, PhD c, Benjamin L. Wright, MD a, b, Jonathan Spergel, MD, PhD c, Nicole Wolfset, MD cRésumé |
Immunotherapy is a treatment approach based on the principle of incremental allergen exposure to achieve desensitization. Recently, oral immunotherapy has been introduced as a treatment of IgE-mediated food allergy. Some patients receiving oral immunotherapy for food allergy may develop eosinophilic esophagitis. Here, we summarize the literature examining this association, its treatment, and outcomes and discuss possible explanations for this clinical phenomenon. We further identify potential associations with aeroallergen sensitivity and other forms of immunotherapy including subcutaneous immunotherapy and sublingual immunotherapy. Finally, we discuss management of immunotherapy-induced eosinophilic esophagitis. Epicutaneous immunotherapy is highlighted as an area of therapeutic investigation.
Le texte complet de cet article est disponible en PDF.Keywords : Eosinophilic gastrointestinal disease, Adverse effects, Oral immunotherapy, Allergy shots, Eosinophil
Plan
| Declaration of funding: B.L. Wright receives support from the NIH/NIAID (K23AI158813). J. Spergel receives support from the NIH/NIAID and the Consortium of Eosinophilic Gastrointestinal Disease Researchers (U54 AI117804). N. Wolfset receives support from an NIH T32 training grant (T32GM008562). M.A. Sacta receives support from the Gail B. Slap Department of Pediatrics Fellowship Award. |
Vol 44 - N° 2
P. 281-291 - mai 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
